Pharmaceuticals In India
- All
- News
- Videos
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested
The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.
-
Cough Syrup Kills 2 Children In Rajasthan; Doctor Takes It To Prove It's Safe And Faints
A generic cough syrup manufactured by a pharmaceutical company for the Rajasthan government has led to the deaths of two children and at least 10 others falling ill in the state over the past two weeks, officials said.
-
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic in India
-
India Offers Expertise To Central American Nations In Digital, Health And Agricultural Sectors
External Affairs Minister S Jaishankar has offered India's expertise to Central American countries in the fields of digital payment system, information technology, pharmaceuticals, and agriculture to tackle shared problems.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
4 Die In Gas Leak At Pharmaceutical Company In Maharashtra's Palghar
Four people died in a gas leak at a pharmaceutical company in Maharashtra's Palghar district.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested
The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.
-
Cough Syrup Kills 2 Children In Rajasthan; Doctor Takes It To Prove It's Safe And Faints
A generic cough syrup manufactured by a pharmaceutical company for the Rajasthan government has led to the deaths of two children and at least 10 others falling ill in the state over the past two weeks, officials said.
-
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic in India
-
India Offers Expertise To Central American Nations In Digital, Health And Agricultural Sectors
External Affairs Minister S Jaishankar has offered India's expertise to Central American countries in the fields of digital payment system, information technology, pharmaceuticals, and agriculture to tackle shared problems.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
4 Die In Gas Leak At Pharmaceutical Company In Maharashtra's Palghar
Four people died in a gas leak at a pharmaceutical company in Maharashtra's Palghar district.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
